Ashland Global Holdings Inc (ASH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Ashland Global Holdings Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 72.60 $ — 99% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -8.6% failed
- More than 10% revenue growth is expected for the coming year 4.4% failed
- Share count grows by less than 3% a year -6.4% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -13.9% failed
- Gross margin at 40% or higher and without meaningful erosion 30.1% failed
- Goodwill from acquisitions does not grow faster than revenue 15.3% passed
- Net debt below twice EBITDA failed
- Operating cash flow covers the profits of the last three years 1,246 m passed
- Return on capital at 15% or higher, or up versus two years ago -18.5% failed
- Insiders hold at least 10% or are net buyers 1.2% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 7.6% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 11
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 09/30/2026 | 3.57 | 3.20 – 3.85 | 1,864 | 5.5% | 12 |
| 09/30/2027 | 4.37 | 3.90 – 4.74 | 1,934 | 22.5% | 12 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -3.51 | -788.60 | 405 | -14.40 | -40.70 | -40 | -63 |
| 2025: Q1 | 0.66 | -72.00 | 479 | -16.70 | 6.50 | 1 | -20 |
| 2025: Q2 | -16.13 | -13,810.90 | 463 | -14.90 | -160.30 | 133 | 113 |
| 2025: Q3 | 0.70 | 113.00 | 478 | -8.40 | 6.70 | 106 | 86 |
| 2025: Q4 | -0.26 | – | 386 | -4.70 | -3.10 | 125 | 111 |
| 2026: Q1 | 0.35 | -47.30 | 482 | 0.60 | 3.30 | 41 | 24 |
| 2026: Q2 | 0.35 | 102.20 | 497 | 7.30 | 3.20 | 120 | 100 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 3,019 | -50 | -29 | -0.46 | 678 | 3,347 | 10,000 |
| 2017 | 2,309 | 49 | 1 | 0.02 | 383 | 3,406 | 8,618 |
| 2018 | 2,589 | 102 | 114 | 1.78 | 297 | 3,406 | 8,252 |
| 2019 | 2,148 | 86 | 505 | 8.02 | 241 | 3,571 | 7,251 |
| 2020 | 2,016 | -461 | -508 | -8.33 | 203 | 3,036 | 6,877 |
| 2021 | 2,111 | 192 | 220 | 3.61 | 560 | 2,752 | 6,612 |
| 2022 | 2,391 | 333 | 927 | 16.55 | -213 | 3,220 | 6,213 |
| 2023 | 2,191 | 172 | 178 | 3.30 | 243 | 3,097 | 5,939 |
| 2024 | 2,113 | -26 | 169 | 3.38 | 411 | 2,868 | 5,645 |
| 2025 | 1,824 | -775 | -845 | -18.37 | 94 | 1,904 | 4,611 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Ashland Inc. bietet Additive und Spezialzutaten in Nord- und Lateinamerika, Europa, im asiatisch-pazifischen Raum und international an.
| Employees | 2,900 |
|---|---|
| Headquarters | Wilmington, DE |
| Address | 8145 Blazer Drive, 19808 Wilmington, United States |
| Phone | 302 995 3000 |
| Website | ashland.com |
| IPO Date | 6. Apr 1983 |
| ISIN | US0441861046 |
| Stock Split | 511:250 on 05/15/2017 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Guillermo Novo | Chairman & CEO | 1962 |
| William C. Whitaker C.F.A. | Senior VP, CFO & Director of Investor Relations | 1989 |
| Osama M. Musa Ph.D. | Senior VP & CTO | 1968 |
| James P. Minicucci | Senior VP & GM of Personal Care | 1982 |
| Alessandra Faccin Assis | Senior VP and GM of Life Sciences & Intermediates | 1980 |
| Wayne Muil | Senior Vice President of Operations | – |
| Samuel A. Richardson | VP, Controller & Principal Accounting Officer | 1979 |
| Robin E. Lampkin | Senior VP, General Counsel & Secretary | 1963 |
| Carolmarie C. Brown | Vice President of Corporate Affairs, Global Marketing, Brand & Business Communications | – |
| Eileen M. Drury | Senior VP & Chief HR Officer | 1968 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Musa Osama M | SVP and CTO | Other | 1,267 | 57.96 | 73,435 |
| 27. Jul 2026 | Assis Alessandra Faccin | SVP and GM, Life Sciences | Other | 884 | 66.38 | 58,680 |
| 27. Jul 2026 | Assis Alessandra Faccin | SVP and GM, Life Sciences | Other | 3,215 | 66.38 | 213,412 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.